First published paper on stem cell therapy for genetic blindness via subtenon injection, 23C Life Science Centre. Read the case report →
Genetic blindness at 23C refers to optic nerve conditions, where the nerve that carries visual signals from the eye to the brain is underdeveloped, damaged, or deteriorating. Conventional medicine has no treatment that addresses the root cause.
Stem cells can regenerate nerve cells in the optic nerve, giving patients the possibility of recovering vision that was previously considered permanent.
Optic nerve atrophy occurs when the optic nerve is damaged, causing partial or total loss of vision as visual signals can no longer travel freely from the retina to the brain. ONA can arise from demyelinating, inflammatory, ischaemic or traumatic origins including glaucoma, optic neuritis, and Leber hereditary optic neuropathy. Our protocols have been treating ONA since 2007.
Optic nerve hypoplasia (ONH) is the leading cause of congenital blindness, occurring in approximately 10 in every 100,000 live births. Septo-optic dysplasia (SOD), also known as de Morsier syndrome, is a subtype of ONH. It involves underdevelopment of the optic nerve, pituitary gland dysfunction, and absence of the septum pellucidum. In addition to vision loss, SOD can cause pituitary deficiency, autistic behaviours, and epileptic seizures. Most cases arise from genetic abnormalities.
Retinitis pigmentosa is a group of inherited retinal disorders in which the light-sensing photoreceptor cells of the retina progressively degenerate — causing night blindness, gradual loss of peripheral vision, and, in advanced stages, central vision. Conventional medicine currently offers no cure. Cell therapy is studied for its potential to support the surviving retinal cells and slow further deterioration.
A unique delivery method that brings stem cells as close as possible to the optic nerve and surrounding tissue. 23C published the world's first scientific paper on this technique for genetic blindness.
Unlike conventional treatment which only helps patients cope, our protocol promotes actual healing of the optic nerve and affected brain structures, not just symptom management.
Stem cell injections are combined with specialised support therapies tailored to each patient's condition profile, designed to maximise neurological recovery and quality of life outcomes.
In documented cases, early improvement has been observed within 24 hours, with light perception returning within 24 hours and colour perception within 72 hours of treatment. The following improvements have been reported by past patients. Results vary by individual, improvements cannot be guaranteed.
Conventional medicine may have nothing left to offer for optic nerve conditions. Our protocols have been regenerating nerve function since 2007. Send us your diagnosis and recent eye imaging, we will review your case personally.
Request a Case Review